Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation Of A Mobile Messaging Service (Text And / Or Graphic) In Improving Adherence With Ensured Supply Of Anti-Seizure Medications In People With Epilepsy In Kilifi And Nairobi, Kenya

NCT05321641 is registered in ClinicalTrials.gov with KEMRI-Wellcome Trust Collaborative Research Program as lead sponsor.

NCT NCT05321641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05321641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation Of A Mobile Messaging Service (Text And / Or Graphic) In Improving Adherence With Ensured Supply Of Anti-Seizure Medications In People With Epilepsy In Kilifi And Nairobi, Kenya
Lead sponsor
KEMRI-Wellcome Trust Collaborative Research Program
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2022
Completion date
December 31, 2024
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, treatment adherence